Observe Medical ASA

OSL-OBSRV
Oslo Børs
Healthcare Medical Devices
Global Rank
#41864
Country Rank
#251
Market Cap
8.46 M
Price
0.0918
Change (%)
0.00%
Volume
30,006

Observe Medical ASA's latest marketcap:

8.46 M

As of 08/14/2025, Observe Medical ASA's market capitalization has reached $8.46 M. According to our data, Observe Medical ASA is the 41864th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 8.46 M
Revenue (ttm) 1.82 M
Net Income (ttm) -5,767,614.07
Shares Out 92.15 M
EPS (ttm) -0.38
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 08/22/2025
Market Cap Chart
Data Updated: 08/14/2025

Observe Medical ASA's yearly market capitalization.

Observe Medical ASA has seen its market value drop from kr179.31 M to kr86.16 M since 2019, representing a total decrease of 51.95% and an annual compound decline rate (CAGR) of 12.22%.
Date Market Cap(kr) Market Cap(USD) Change (%) Global Rank
08/14/2025 kr86.16 M $8.46 M -16.92% 41864
12/30/2024 kr103.71 M $9.11 M 66.57% 38454
12/29/2023 kr62.26 M $6.11 M -51.3% 38999
12/30/2022 kr127.85 M $13.03 M -66.9% 34820
12/30/2021 kr386.23 M $43.74 M 42.24% 28353
12/30/2020 kr271.54 M $31.64 M 51.44% 27248
12/30/2019 kr179.31 M $20.42 M 26308

Company Profile

About Observe Medical ASA

Observe Medical ASA is a medical technology company focused on developing and commercializing innovative healthcare solutions for patients, professionals, and hospitals. Operating in Norway, Sweden, the United States, and across Europe, the company delivers advanced products designed to enhance patient care and clinical efficiency.

Key Products & Solutions

  • Sippi – A digital, automated urine measurement system for precise monitoring and biofilm control.
  • Biim – A portable, wireless ultrasound device providing real-time imaging for medical staff.
  • Unometer Series – Includes Unometer, Safeti Plus, Unometer 500, and UnoMeter for accurate urine drainage, collection, and measurement.
  • AbdoPressure – A specialized product for managing patient fluid drainage.

Areas of Expertise

Observe Medical ASA specializes in:

  • Urine measurement technologies
  • Anesthesiology and ICU solutions
  • Wound care products

Founded: 2009
Headquarters: Oslo, Norway

Frequently Asked Questions

  • What is Observe Medical ASA's (OSL-OBSRV) current market cap?
    As of 08/14/2025, Observe Medical ASA (including the parent company, if applicable) has an estimated market capitalization of $8.46 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Observe Medical ASA global market capitalization ranking is approximately 41864 as of 08/14/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.